Antiviral Strategies for Pandemic and Seasonal Influenza

While vaccines are the primary public health response to seasonal and pandemic flu, short of a universal vaccine there are inherent limitations to this approach. Antiviral drugs provide valuable alternative options for treatment and prophylaxis of influenza. Here, we will review drugs and drug candi...

Full description

Bibliographic Details
Main Authors: Fang Fang, Maria Hedlund, Jeffrey L. Larson
Format: Article
Language:English
Published: MDPI AG 2010-08-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/2/8/1766/
_version_ 1819041036701270016
author Fang Fang
Maria Hedlund
Jeffrey L. Larson
author_facet Fang Fang
Maria Hedlund
Jeffrey L. Larson
author_sort Fang Fang
collection DOAJ
description While vaccines are the primary public health response to seasonal and pandemic flu, short of a universal vaccine there are inherent limitations to this approach. Antiviral drugs provide valuable alternative options for treatment and prophylaxis of influenza. Here, we will review drugs and drug candidates against influenza with an emphasis on the recent progress of a host-targeting entry-blocker drug candidate, DAS181, a sialidase fusion protein.
first_indexed 2024-12-21T09:18:37Z
format Article
id doaj.art-62cc3dfae3ff4645b9591959408629f6
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-12-21T09:18:37Z
publishDate 2010-08-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-62cc3dfae3ff4645b9591959408629f62022-12-21T19:09:05ZengMDPI AGViruses1999-49152010-08-01281766178110.3390/v2081766Antiviral Strategies for Pandemic and Seasonal InfluenzaFang FangMaria HedlundJeffrey L. LarsonWhile vaccines are the primary public health response to seasonal and pandemic flu, short of a universal vaccine there are inherent limitations to this approach. Antiviral drugs provide valuable alternative options for treatment and prophylaxis of influenza. Here, we will review drugs and drug candidates against influenza with an emphasis on the recent progress of a host-targeting entry-blocker drug candidate, DAS181, a sialidase fusion protein.http://www.mdpi.com/1999-4915/2/8/1766/influenza virusneuraminidase inhibitorssialic acidRNA polymerase
spellingShingle Fang Fang
Maria Hedlund
Jeffrey L. Larson
Antiviral Strategies for Pandemic and Seasonal Influenza
Viruses
influenza virus
neuraminidase inhibitors
sialic acid
RNA polymerase
title Antiviral Strategies for Pandemic and Seasonal Influenza
title_full Antiviral Strategies for Pandemic and Seasonal Influenza
title_fullStr Antiviral Strategies for Pandemic and Seasonal Influenza
title_full_unstemmed Antiviral Strategies for Pandemic and Seasonal Influenza
title_short Antiviral Strategies for Pandemic and Seasonal Influenza
title_sort antiviral strategies for pandemic and seasonal influenza
topic influenza virus
neuraminidase inhibitors
sialic acid
RNA polymerase
url http://www.mdpi.com/1999-4915/2/8/1766/
work_keys_str_mv AT fangfang antiviralstrategiesforpandemicandseasonalinfluenza
AT mariahedlund antiviralstrategiesforpandemicandseasonalinfluenza
AT jeffreyllarson antiviralstrategiesforpandemicandseasonalinfluenza